Diagnostic Value of Salivary MiRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jul 2

PMID 34209954

Citations 19

Authors

Jeong-Wook Kang

Young-Gyu Eun

Young-Chan Lee

Affiliations

Soon will be listed here.

Abstract

Several studies have highlighted the diagnostic potential of salivary microRNA (miRNA) in head and neck squamous cell cancer (HNSCC). The purpose of this meta-analysis was to summarize published studies and evaluate the diagnostic accuracy of salivary miRNA in HNSCC detection. In this meta-analysis, we systematically searched PubMed, EMBASE, and Cochrane Library databases for studies on miRNA and HNSCC diagnosis. Pooled sensitivity, specificity, and diagnostic odds ratio (DOR) with a summary receiver-operating characteristic curve were calculated using a bivariate random-effect meta-analysis model. Furthermore, subgroup analyses were conducted to explore the main sources of heterogeneity. Seventeen studies from ten articles, including 23 miRNA and a total of 759 subjects, were included in this meta-analysis. The pooled sensitivity and specificity of salivary miRNA in the diagnosis of HNSCC were 0.697 (95% CI: 0.644-0.744) and 0.868 (95% CI: 0.811-0.910), respectively. The overall area under the curve was 0.803 with a DOR of 12.915 (95% CI: 9.512-17.534). Salivary miRNAs are a promising non-invasive diagnostic biomarker with moderate accuracy for HNSCC. These results must be verified by large-scale prospective studies.

Citing Articles

Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers.

Nejat Dehkordi A, Maddahi M, Vafa P, Ebrahimi N, Aref A Clin Transl Oncol. 2024; .

PMID: 39377974 DOI: 10.1007/s12094-024-03742-8.

The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives.

Romani C, Assoni C, Mattavelli D, Rampinelli V, Piazza C Acta Otorhinolaryngol Ital. 2024; 44(5):279-284.

PMID: 39283255 PMC: 11556778. DOI: 10.14639/0392-100X-N2981.

Exploring Salivary Biomarkers for Tumor Diagnosis: A Narrative Review.

Ghosh A, Nath A, Elangovan E, Banerjee A, Ramalingam K, Sethuraman S Cureus. 2024; 16(7):e65725.

PMID: 39211674 PMC: 11358853. DOI: 10.7759/cureus.65725.

A Roadmap for the Rational Use of Biomarkers in Oral Disease Screening.

Cirillo N Biomolecules. 2024; 14(7).

PMID: 39062501 PMC: 11274832. DOI: 10.3390/biom14070787.

Novel non-invasive molecular signatures for oral cavity cancer, by whole transcriptome and small non-coding RNA sequencing analyses: Predicted association with PI3K/AKT/mTOR pathway.

Vageli D, Doukas P, Townsend J, Pickering C, Judson B Cancer Med. 2024; 13(11):e7309.

PMID: 38819439 PMC: 11141334. DOI: 10.1002/cam4.7309.

References

Park N, Zhou H, Elashoff D, Henson B, Kastratovic D, Abemayor E . Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009; 15(17):5473-7. PMC: 2752355. DOI: 10.1158/1078-0432.CCR-09-0736. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Economopoulou P, de Bree R, Kotsantis I, Psyrri A . Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting. Front Oncol. 2019; 9:827. PMC: 6727245. DOI: 10.3389/fonc.2019.00827. View

Ruan K, Fang X, Ouyang G . MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 2009; 285(2):116-26. DOI: 10.1016/j.canlet.2009.04.031. View

Langevin S, Kuhnell D, Parry T, Biesiada J, Huang S, Wise-Draper T . Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells reveals common secretion profiles and potential utility as salivary biomarkers. Oncotarget. 2017; 8(47):82459-82474. PMC: 5669904. DOI: 10.18632/oncotarget.19614. View

Michael A, Bajracharya S, Yuen P, Zhou H, Star R, Illei G . Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 2009; 16(1):34-8. PMC: 2844919. DOI: 10.1111/j.1601-0825.2009.01604.x. View

Gaba F, Sheth C, Veses V . Salivary biomarkers and their efficacies as diagnostic tools for Oral Squamous Cell Carcinoma: Systematic review and meta-analysis. J Oral Pathol Med. 2018; 50(3):299-307. DOI: 10.1111/jop.12791. View

Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C . Salivary microRNAs in oral cancer. Oral Dis. 2015; 21(6):739-47. DOI: 10.1111/odi.12340. View

Nagadia R, Pandit P, Coman W, Cooper-White J, Punyadeera C . miRNAs in head and neck cancer revisited. Cell Oncol (Dordr). 2013; 36(1):1-7. DOI: 10.1007/s13402-012-0122-4. View

10.

Wang Z, Li F, Rufo J, Chen C, Yang S, Li L . Acoustofluidic Salivary Exosome Isolation: A Liquid Biopsy Compatible Approach for Human Papillomavirus-Associated Oropharyngeal Cancer Detection. J Mol Diagn. 2019; 22(1):50-59. PMC: 6943372. DOI: 10.1016/j.jmoldx.2019.08.004. View

11.

Duz M, Karatas O, Guzel E, Turgut N, Yilmaz M, Creighton C . Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study. Cell Oncol (Dordr). 2015; 39(2):187-93. DOI: 10.1007/s13402-015-0259-z. View

12.

Ding Y, Ma Q, Liu F, Zhao L, Wei W . The Potential Use of Salivary miRNAs as Promising Biomarkers for Detection of Cancer: A Meta-Analysis. PLoS One. 2016; 11(11):e0166303. PMC: 5104484. DOI: 10.1371/journal.pone.0166303. View

13.

Lubov J, Maschietto M, Ibrahim I, Mlynarek A, Hier M, Kowalski L . Meta-analysis of microRNAs expression in head and neck cancer: uncovering association with outcome and mechanisms. Oncotarget. 2017; 8(33):55511-55524. PMC: 5589676. DOI: 10.18632/oncotarget.19224. View

14.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

15.

Gai C, Camussi F, Broccoletti R, Gambino A, Cabras M, Molinaro L . Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma. BMC Cancer. 2018; 18(1):439. PMC: 5907383. DOI: 10.1186/s12885-018-4364-z. View

16.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

17.

Rapado-Gonzalez O, Martinez-Reglero C, Salgado-Barreira A, Lopez-Lopez R, Suarez-Cunqueiro M, Muinelo-Romay L . miRNAs in liquid biopsy for oral squamous cell carcinoma diagnosis: Systematic review and meta-analysis. Oral Oncol. 2019; 99:104465. DOI: 10.1016/j.oraloncology.2019.104465. View

18.

Sabarimurugan S, Kumarasamy C, Baxi S, Devi A, Jayaraj R . Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma. PLoS One. 2019; 14(2):e0209760. PMC: 6368411. DOI: 10.1371/journal.pone.0209760. View

19.

Momen-Heravi F, Trachtenberg A, Kuo W, Cheng Y . Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. J Dent Res. 2014; 93(7 Suppl):86S-93S. PMC: 4107544. DOI: 10.1177/0022034514531018. View

20.

He L, Ping F, Fan Z, Zhang C, Deng M, Cheng B . Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening. Biomed Pharmacother. 2019; 121:109553. DOI: 10.1016/j.biopha.2019.109553. View